5 completed, 1 terminated, 1 withdrawn. 7 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Terminated 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 5, Terminated 1 |
Follow Milk Hypersensitivity: new trials by email Literature Review of Milk Hypersensitivity trials Research Report on Milk Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy | Phase 1 | Withdrawn | Candid Therapeutics | 2026-04-01 | 2026-07-22 | |
| Open-label Extension Study of ADP101 ADP101 - Food Allergy | Phase 1 / Phase 2 | Terminated | Alladapt Immunotherapeutics, Inc. | 45 | 2022-03-14 | 2024-03-26 |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Alladapt Immunotherapeutics, Inc. | 73 | 2021-04-20 | 2024-05-16 |
| Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Viaskin Milk 150 mcg, Viaskin Milk 300 mcg, Viaskin Milk 500 mcg - Food Allergy | Phase 1 / Phase 2 | Completed | DBV Technologies | 198 | 2014-11-01 | 2024-11-20 |
| The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy Milk Protein Extract Immunotherapy goal of 4mg/day, Milk Protein Extract Immunotherapy goal of 7mg/day, Milk Powder Immunotherapy goal dose 2000 mg/day - Milk Allergy | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 30 | 2008-08-01 | 2017-05-15 |
| A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy cow's milk powder, Placebo - Milk Hypersensitivity | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 20 | 2006-08-01 | 2017-04-20 |
| Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques). Procedure - Milk Allergy | Phase 1 / Phase 2 | Completed | Nambudripad's Allergy Research Foundation | 26 | 2005-01-01 | 2006-05-22 |
Food Hypersensitivity (6) · Egg Hypersensitivity (3) · Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Nut Hypersensitivity (3) · Peanut Hypersensitivity (3) · Wheat Hypersensitivity (3) · Immune System Diseases (2) · Shellfish Hypersensitivity (2) · Asthma (1) · Dermatitis, Atopic (1) · Rhinitis, Allergic (1) · Rhinosinusitis (1) · Urticaria (1)
Immune System Diseases (5) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Nut and Peanut Hypersensitivity (3) · Bronchial Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dermatitis (1) · Food Hypersensitivity (1) · Genetic Diseases, Inborn (1) · Infections (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Paranasal Sinus Diseases (1)
Methods (1)
Alladapt Immunotherapeutics, Inc. (2) · Johns Hopkins University (2) · Candid Therapeutics (1) · DBV Technologies (1) · Nambudripad's Allergy Research Foundation (1)
United States (6) · Australia (1) · Canada (1)
Mei-Lun Wang, MD (2) · Devi S Nambudripad, DC,PhD,L.Ac (1) · Robert A Wood, MD (1) · Robert Wood, MD (1)